Business Wire

Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO (fluralaner) Chews for Dogs

MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced ...
Earth.com

FDA approves an injection that protects dogs from fleas and ticks for a whole year

FDA approves Bravecto Quantum (fluralaner), the first annual injection against fleas and ticks in dogs, offering 12 months of ...
ABC7

FDA approves long-acting flea treatment for dogs, marking veterinary breakthrough

Dogs across the U.S. could soon get longer-lasting protection against pesky parasites thanks to a new treatment approved by federal regulators Thursday. NOTE: This video is from a previous report. The ...
Morningstar

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

12-Month Parasiticide Treatment for Dogs Offers Unrivaled Duration of Flea and Tick Protection Compared to Existing Products Merck Animal Health, known as MSD Animal Health outside of the United ...
Insurancenewsnet.com

MSD Animal Health Receives Positive Opinion from European Medicines Agency for BRAVECTO® Plus (fluralaner plus moxidectin) Spot-on Solution for Cats

MADISON, N.J.--(BUSINESS WIRE)-- MSD Animal Health (known as Merck Animal Health in the United States and Canada) today announced that the Committee for Medicinal Products for Veterinary Use (CVMP) of ...